Top Wall Street analysts are betting on stocks like Tesla and Uber for the third quarterCNBC • 07/05/20
New Findings on Gilead’s Biktarvy® Presented at AIDS 2020: Virtual Include Positive Switch Data in Older AdultsBusiness Wire • 07/04/20
Gilead Sciences Presents Data Supporting a Potential Six-Month Dosing Interval for Investigational HIV-1 Capsid Inhibitor Lenacapavir (GS-6207)Business Wire • 07/04/20
Gilead granted conditional approval for Covid-19 treatment remdesivir in EuropeMarket Watch • 07/03/20
European Commission Grants Conditional Marketing Authorization for Gilead’s Veklury® (remdesivir) for the Treatment of COVID-19Business Wire • 07/03/20
UPDATE: U.S. government to secure majority of Gilead's remdesivir supply through SeptemberMarket Watch • 07/01/20
Gilead Sciences Demonstrates Commitment to Scientific Innovation In HIV With New Prevention, Treatment and Cure Research Data Presented At AIDS 2020: VirtualBusiness Wire • 07/01/20
Gilead Fixes the Price of COVID-19 Drug Remdesivir; the Government Secures the Bulk of Its SupplyThe Motley Fool • 06/29/20
Is Gilead's Coronavirus Drug On Track To Become A Mega-Blockbuster?Investors Business Daily • 06/29/20